First identification of blaOXA-51-like in non-baumannii acinetobacter spp.

Journal of Chemotherapy

Volumn 21, Issue 5, 2009, Pages 514-520

  Lee, Yi Tzu ^a,b   Turton, J F ^c   Chen, Te Li ^b,d   Wu, R Chen Chih ^d   Chang, Wei Che ^d   Fung, Chang Phone ^b,d   Chen, Chien Pei ^b   Cho, Wen Long ^d   Huang, Li Yueh ^e   Siu, L K ^e  

^a Chutung Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Acinetobacter baumannii; Non baumannii Acinetobacter spp.

Indexed keywords

CARBAPENEMASE; DNA 16S; DNA 23S; IMIPENEM; MEROPENEM; RIBOSOME DNA; SPACER DNA; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; RNA 16S; RNA 23S;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL GENE; BACTERIUM TRANSFORMATION; BLA GENE; DNA RESTRICTION; DNA SEQUENCE; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; RECOMBINANT PLASMID; SPECIES IDENTIFICATION; ANTIBIOTIC RESISTANCE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BLOTTING, SOUTHERN; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 23S;

EID: 75549089284     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2009.21.5.514     Document Type: Article

References (32)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996: 9(2): 148-65.
2. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12(9): 826-36.
3. Heritier C, Poirel L, Foumier PE, Claverie JM, Raoult D. Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49(10): 4174-9.
4. Merkier AK, Centron D. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents 2006; 28(2): 110-3.
5. OXA 51 like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44(8): 2974-6.
6. Turton JF. Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM et al. The role of ISAbal in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258(1): 72-7.
7. Chen TL, Siu LK, Wu RC, Shaio MF, Huang LY, Fung CP et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13(8): 801-6.
8. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43(4): 1632-9.
9. Ibrahim A, Gerner-Smidt P, Liesack W. Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47(3): 837-41.
10. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33(1): 11-5.
11. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. Clin Microbiol 2006. 44(3): 827-32.
12. Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCRbased method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect 2007; 13(12): 1199-201.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth infomational supplement. M100-S19. Wayne, PA: CL; 2009.
14. Woodford N, Ellington MJ, Coelho JM, Turton JF. Ward ME, Brown S et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27(4): 351-3.
15. OXA-58 in Acinetobacter haumannii. Antimicrob Agents Chemother 2006; 50(4): 1442-8.
16. VIM, a new integron borne metallo beta lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43(7): 1584-90.
17. Osano E, Arakawa Y, Wacharotayankun R, Ohta M. Horii T, Ito H et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994; 38(1): 71-8.
18. Poirel L. Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44(4): 891-7.
19. Pasteran F. Rapoport M, Petroni A, Faccone D, Corso A. Galas M et al. Emergence of PER 2 and VEB la in Acinetobacter baumannii Strains in the Americas. Antimicrob Agents Chemother 2006; 50(9): 3222-4.
20. GIM l, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother 2004; 48(12): 4654-61.
21. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44(9): 3139 44.
22. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41(10): 4623-9.
23. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA 40. Antimicrob Agents Chemother 2006; 50(9): 2941-5.
24. Sambrook J, Russel DW. Molecular Cloning: A Labora tory Manual, 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 2001.
25. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, - 24/40 and - 58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009; 63(1): 55-9.
26. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51(11): 4022 8.
27. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D {beta}-Lactamase involved in resistance to carbapenems in Acinetobacter baumannii, Antimicrob Agents Chemother 2007; 51(11): 4022 8.
28. Marti S, Sanchez-Cespedes J. Blasco MD, Espinal P. Ruiz M, Alba V et al. Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ctl3TU Clinical isolate. Diagn Microbiol Infect Dis 2008; 61(4): 468 70.
29. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008; 52(4): 1252-6.
30. Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF. An OXA-66/OXA 51 like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob Agents Chemother 2007: 51(11): 3844-52.
31. Ruiz M, Marti S, Femandez Cuenca F, Pascual A, Vila J. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 2007; 13(12): 1192 8.
32. ABA1 customized for Acinetobacter? FEMS Microbiol Lett 2005; 243(2): 425-9,